Company Overview
PharmaCyte Biotech is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed.
Recent News
PharmaCyte Biotech Begins Physical Testing of CypCaps in Response to FDA Recommendations for its Clinical Trial Product
Stock Overview
01/15/2021 03:59 PM EST
Investor Relations
PharmaCyte Biotech, Inc.
Investor Relations Department
T: 917-595-2856
Info@PharmaCyte.com